Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.
Watanabe M, Kawaguchi T, Isa S, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Sakamoto K, Matsumura A, Koh Y. Watanabe M, et al. Among authors: kataoka k. Clin Cancer Res. 2015 Aug 1;21(15):3552-60. doi: 10.1158/1078-0432.CCR-14-2151. Epub 2015 Apr 16. Clin Cancer Res. 2015. PMID: 25882755
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.
Watanabe M, Kawaguchi T, Isa SI, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kawashima O, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Watanabe K, Matsumura A, Koh Y. Watanabe M, et al. Among authors: kataoka k. EBioMedicine. 2017 Jul;21:86-93. doi: 10.1016/j.ebiom.2017.06.003. Epub 2017 Jun 7. EBioMedicine. 2017. PMID: 28625519 Free PMC article.
Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.
Tamiya A, Koh Y, Isa SI, Kubo A, Ando M, Saka H, Yoshimoto N, Takeo S, Adachi H, Tagawa T, Kawashima O, Yamashita M, Kataoka K, Takenoyama M, Takeuchi Y, Watanabe K, Matsumura A, Kawaguchi T. Tamiya A, et al. Among authors: kataoka k. Cancer Med. 2020 Apr;9(7):2343-2351. doi: 10.1002/cam4.2897. Epub 2020 Feb 5. Cancer Med. 2020. PMID: 32022477 Free PMC article.
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study.
Kawaguchi T, Koh Y, Ando M, Ito N, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Serizawa M, Tamiya A, Shimizu S, Yoshimoto N, Kubo A, Isa S, Saka H, Matsumura A. Kawaguchi T, et al. Among authors: kataoka k. J Clin Oncol. 2016 Jul 1;34(19):2247-57. doi: 10.1200/JCO.2015.64.2322. Epub 2016 May 9. J Clin Oncol. 2016. PMID: 27161973
Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.
Okumura N, Sonobe M, Okabe K, Nakamura H, Kataoka M, Yamashita M, Nakata M, Kataoka K, Yamashita Y, Soh J, Yoshioka H, Hotta K, Matsuo K, Sakamoto J, Toyooka S, Date H. Okumura N, et al. Among authors: kataoka m, kataoka k. Int J Clin Oncol. 2017 Apr;22(2):274-282. doi: 10.1007/s10147-016-1067-9. Epub 2016 Dec 5. Int J Clin Oncol. 2017. PMID: 27921177
Clinical Features of Patients With Second Primary Lung Cancer After Head and Neck Cancer.
Takatsu F, Suzawa K, Okazaki M, Shien K, Yamamoto H, Watanabe M, Hayama M, Ueno T, Sugimoto R, Maki Y, Fujiwara T, Okita R, Inokawa H, Tao H, Hirami Y, Matsuda E, Kataoka K, Yamashita M, Sano Y, Matsuura M, Mizutani H, Toyooka S. Takatsu F, et al. Among authors: kataoka k. Ann Thorac Surg. 2024 Jan;117(1):181-188. doi: 10.1016/j.athoracsur.2022.04.052. Epub 2022 May 17. Ann Thorac Surg. 2024. PMID: 35595090 Free article.
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
Okumura N, Soh J, Suzuki H, Nakata M, Fujiwara T, Nakamura H, Sonobe M, Fujinaga T, Kataoka K, Gemba K, Kataoka M, Hotta K, Yoshioka H, Matsuo K, Sakamoto J, Date H, Toyooka S. Okumura N, et al. Among authors: kataoka m, kataoka k. BMC Cancer. 2021 May 6;21(1):506. doi: 10.1186/s12885-021-08232-6. BMC Cancer. 2021. PMID: 33957881 Free PMC article. Clinical Trial.
Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.
Soh J, Okumura N, Nakata M, Nakamura H, Fukuda M, Kataoka M, Kajiwara S, Sano Y, Aoe M, Kataoka K, Hotta K, Matsuo K, Toyooka S, Date H. Soh J, et al. Among authors: kataoka m, kataoka k. Jpn J Clin Oncol. 2016 Aug;46(8):741-7. doi: 10.1093/jjco/hyw062. Epub 2016 May 20. Jpn J Clin Oncol. 2016. PMID: 27207886 Free PMC article. Clinical Trial.
Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.
Tao H, Soh J, Yamamoto H, Fujiwara T, Ueno T, Hayama M, Okazaki M, Sugimoto R, Yamashita M, Sano Y, Okabe K, Matsuura M, Kataoka K, Moriyama S, Toyooka S, Miyoshi S. Tao H, et al. Among authors: kataoka k. J Thorac Dis. 2017 Nov;9(11):4325-4335. doi: 10.21037/jtd.2017.10.70. J Thorac Dis. 2017. PMID: 29268501 Free PMC article.
A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer.
Yamashita Y, Kataoka K, Ishida T, Matsuura M, Seno N, Mukaida H, Miyahara E, Miyata Y, Okita R, Shimizu K, Watari M, Okumichi T, Okada M. Yamashita Y, et al. Among authors: kataoka k. J Thorac Oncol. 2008 Jun;3(6):612-6. doi: 10.1097/JTO.0b013e318174e05e. J Thorac Oncol. 2008. PMID: 18520800 Free article. Clinical Trial.
2,370 results